Swertiamarin is an active compound extracted from Enicostemma littorally bioavailablee possesses antidiabetic activity and enhances β cell regeneration which causes reversal of diabetes. Swertiamarin possesses antihyperglycemic, antihyperlipidemic, cytoprotective, and immune reactivity and also a broad spectrum potential of treating diabetes and other complications related to diabetes. References: Leong XY, Thanikachalam PV, Pandey M, Ramamurthy S. A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases. Biomed Pharmacother. 2016 Dec;84:1051-1060. doi: 10.1016/j.biopha.2016.10.044. Epub 2016 Oct 22. Review. PubMed PMID: 27780133.

纯度：≥98%

CAS：17388-39-5